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A B S T R A C T
The purpose of this study is to analyze clinical experience about the effects of human
amniotic membrane transplantation in eyes with neurotrophic ulcers. In 11 eyes the ap-
plication of amniotic membrane was performed since January 1999 because of neuro-
trophic ulcers. The follow up period was longer than 12 months: 19.76.0 months. The
average healing period after the surgery was 1.60.6 weeks. All corneas were fluorescein
negative even 12 months after operation. Visual acuity after the transplantation was
similar to the one before the surgery in 8 eyes. In 3 eyes the visual acuity after the sur-
gery was better than before. Amniotic membrane transplantation can be considered an
effective alternative for treating persistent epithelial defects such as neurotrophic ulcers.
It has some advantages over corneal transplantation: a relatively simple procedure, no
allograft rejection and it could be particularly beneficial in countries where cornea shor-
tage is apparent.
Introduction
Management of ocular surface distur-
bances still remains as therapeutically
problem despite various conservative and
surgical treatments. For some of them
previously had no effective management
was available so they lead to loss of vi-
sion, especially if there was no normal oc-
ular surface defense and healthy limbal
cells were lacking.
One of such conditions is neurotrophic
corneal ulcer developed as a result of in-
terruption of the corneal derived sensory
afferent nerve anywhere along the course
of the ophthalmic division of the trige-
minal nerve. The ophthalmic division of
trigeminal nerve supplies sensory inner-
vation to the cornea, the conjunctiva as
well as upper and lower eyelids. There-
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fore trigeminal denervation abolishes re-
flexes controlling tear secretion and lid
blinking and closure. This innervation
constitutes the basic neuroanatomical in-
tegration of the entire ocular surface de-
fence1. If the sensory nerve, anywhere
along its course, is interrupted it may re-
sult in neurotrophic keratopathy. The
consequence is corneal anesthesia with
frequent breakdown of corneal epithelial
surface which can cause neurotrophic ul-
cers2.
Exogenous and endogenous factors
and influences like herpetic infection,
corneal burns, tumors, radiation, retro-
bulbar injection for eye surgery or neuro-
surgery could lead to this condition3,4.
If neurotrophic ulcers persist (longer
than 3 weeks) some conventional treat-
ments like topical artificial tears and lu-
bricants are indicated. Some new tech-
niques have been studied: application of
insulin like growth factor, cyanoacrylat
glue, conjunctival flaps, tarsorrhaphy or
lamellar or penetrating keratoplasty5.
Lee and Tseng first introduced in 1997
the use of amniotic membrane in the
treatment of persistent epithelial corneal
ulcers6. The procedure has been shown to
promote epithelial healing, reduce vascu-
larization, yield good cosmetic effect and
is relatively easy to perform. Kruse et al.
(1999) also reported a rapid healing of
corneal surface7.
The aim of this study was to deter-
mine the effect of human amniotic mem-
brane transplantation (mono or multila-
yer; AMT) on neurotrophic corneal ulcers.
Material and Methods
Human amniotic membrane was pre-
pared and preserved as previously de-
scribed7. Amniotic membrane with an at-
tached placenta was obtained shortly
after Caesarian section. By serological
testing human immunodeficiency virus
(HIV), hepatitis virus type B and C and
syphilis had been excluded. The placenta
was cleaned by washing with BSS con-
taining penicillin (50 g/ml), streptomycin
(50 g/ml), neomycin (100 g/ml), and
amphotericin B (2.5 g/ml). The amniotic
membrane was separated from the cho-
rion and was flattened over a nitro-cellu-
lose filter paper with epithelial surface
up, and the stromal matrix down in con-
tact with the paper. Prepared amnion
was placed in a plastic container and
stored at –80 °C.
All surgeries were performed with the
patient receiving parabulbar anesthesia
(2% lidocain). After anesthesia in eyes
with persistent sterile corneal ulceration
the base of the ulcer was debrided and
poorly adherent epithelium adjacent to
the edge of the ulcer was removed up to
the area where the epithelium became
adherent. The amniotic membrane was
removed from the storage medium peeled
from the filter paper. Then it was placed
on the surface of the cornea to cover the
ulcerated area with the epithelial surface
up. Deep ulcers were filled with more
than one layer of amniotic membrane.
The amniotic membrane was secured to
the edge of the defect by interrupted 10.0
nylon sutures. After the transplantation,
bandage contact lens was applied in 10
eyes and partial tarsorrhaphy was added
in 1 eye. In the postoperative period topi-
cal Maxitrol (neomycin sulphate, ploy-
myxin B sulphate and dexamethasone)
was administrated 4 times a day until
complete epithelization was present.
Result of the surgery was evaluated
by patients' symptoms (pain, discomfort
or irritation), inflammation signs and
healing time of the operated eye. Fluo-
rescein staining was used to detect epi-
thelial defects. All patients were exam-
ined on the first postoperative day, at the
end of the first postoperative week, as
well as second, third and fourth postoper-
ative week and monthly thereafter. Cor-
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1. 31 M neuroma L/n 88 art. tears 2 layers 1 14 0.01 0.01
2. 27 M neuroma L/n 57 art. tears 2 layers 1 19 0.1 0.1
3. 46 M neuroma L/c 91 art. tears CL 2 layers 2 13 NLP NLP
4. 37 F neuroma R/c 141 art. tears monolayer 1 28 0.05 0.05
5. 50 M alk. burns L/c 11 art. tears 2 layers 2 15 PKP in 16th week LP LP
6. 48 F alco. inj. R/i 173 art. tears monolayer 2 30 0.1 0.2





8. 61 F retro.injection R/i 107
punctual
occlusion monolayer 2 17 NLP NLP
9. 47 F excision ofteeth R/i 73 art. tears monolayer 2 33 diabetes mellitus 0.5 0.5
10. 36 F multipleeye op. L/i 89 art. tears 2 layers 3 12
lupus
erythematosus LP LP
11. 29 M herpeszoster L/c 103 tarsorrhaphy 2 layers 1 15
schizophrenia
lost graft: re-graft-
ing after 4 days
0.1 0.5
AMT = amniotic membrane transplantation, M = male, F = female, R = right eye, L = left eye, c = central part of cornea, n = nasal part of cornea,
i = inferior part of cornea, alk. burns = alkali burns, alco.inj. = alcohol injection, op. = operations, art.tears = artificial tears, CL = contact
lens,PKP = penetrating keratoplasty , pre.VA = preoperative visual acuity, post.VA = postoperative visual acuity, NLP = no light perception,
LP = light perception
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neal epithelization healing was classified
as success or failure.
The preoperative and postoperative
data were analyzed by 2 and t test, and p




was performed in 11 patients (11 eyes)
with neurotrophic ulcers (Table 1).
The mean age of patients was 38.5
10.8 years (ages between 12 and 61), 5
patients were females (45.5%) and 6 ma-
les (54.5%). In 4 patients the cause of
neurotrophic problems with cornea was
acoustic neuroma surgery, one patient
has developed corneal ulcer after alcohol
injection because of trigeminal neuralgia,
and one patient after extraction of right
upper molar and cross section of arteria
temporalis superficialis (so called vascu-
lar decompression to perform sympathe-
tic denervation) performed by a neuro-
surgeon because of intensive pain after
the tooth extraction (Figure 1). After this
surgery patient still had pain in the re-
gion of inervation of nervus maxillaris
and auriculotemporalis. One year later
decreased corneal sensitivity was found
and she developed a neurotrophic ulcer.
One patient (12 years old ) has developed
epithelial defects due to the meningitis
which he had during varicella infection in
age of 2. His first problems with cornea
occurred at the age of 8. He was treated
with artificial tears, resurfacing gels and
contact lens – without any result. In four
patients the reason for developing neuro-
trophic ulcer was direct ocular damage:
in one patient the ulcer was caused by al-
kali burns of cornea, in one patient by
herpes zoster ophthalmicus, and two pa-
tients have had multiple eye surgeries: in
one patient corneal ulcer developed due
to multiple surgeries of retinal detach-
ment (conventional surgery twice and vi-
trectomy with silicon oil once) and in one
patient, who was previously operated by
trabeculectomy, after retrobulbar injec-
tion of 2% lidocain because of extracap-
sular cataract extraction. In this patient
amaurosis developed immediately after
injection. After 2 months neurotrophic ul-
cer was proven (Table 1).
The duration of persistent corneal ul-
cera varied from 11 weeks up to 4 years
with an average of 103.138.1 weeks, i.e.
almost 2 years. All patients were initially
treated with artificial tears and resurfac-
ing lubricants or contact lenses and pro-
phylactic antibiotics but there were no re-
sults. In one patient punctual occlusion
by cauterization was performed as well in
one partial tarsorrhaphy.
One patient had diabetes mellitus, one
lupus erythematodes, one patient suffe-
red from schizophrenia and one had epi-
lepsy. The ulcer was located in 5 patients
in central cornea, in 4 patients in inferior
periphery of cornea and in 2 patient in
nasal periphery of cornea.
The average healing period was 1.60.6
weeks. The longest healing period was in
the patient with diabetes mellitus despite
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Fig 1. Neurotrophic ulcer of young boy who had meningitis in age of 2 (A). The same cornea 16
months after application of amniotic membrane (B). Deep persisting ulcer on inferior part of cor-
nea in patient who developed neurotrophic ulcer after retrobulbar injection of 2% lidocain because
of extracapsular cataract extraction: preoperatively (C), postoperatively (D). Fluorescein positive
inferior cornea of the patient who underwent excision of the right upper molar(E) and fluorescein
negative cornea 2 months after amniotic membrane transplantation (F). Central neurotrophic per-
sistent ulcer in patient with schizophrenia (G) and fluorescein negative cornea 12 months after ope-
ration (H).

the fact that in this patient multilayer
amniotic membrane was transplanted.
One patient has lost his graft on the 6th
day after the surgery, so new application
of amniotic membrane was necessary. The
follow up period was 19.76.0 months. All
eyes were followed up more than one year
and in all eyes even 12 months or longer
after operation epithelization was pres-
ent, except in one patient. In the eye of a
boy who had his ulcera due to varicella
meningitis in childhood (12 years old), 21
months after operation neurotrophic ul-
cer occurred as recidive. We have per-
formed new application of amniotic mem-
brane, but since only 12 weeks have
passed after the second surgery the data
concerning the success of this re-opera-
tion could not be included in this study.
Neurotrophic ulcera were in 5 eyes sit-
uated centrally, in 2 patients in the nasal
periphery of cornea and in 4 eyes in infe-
rior corneal periphery. Postoperative vi-
sual acuity was improved in 3 eyes and
has shown no change in 8 eyes. There was
no worsening in visual acuity as com-
pared to the preoperative period in any
patient (Table 1). However visual acuity
was not the parameter for evaluating the
success of operation.
Discussion
In this study we have evaluated the ef-
ficacy and safety of amniotic membrane
transplantation in neurotrophic ulcera.
The common feature of all the analyzed
patients was the fact that persistent epi-
thelial defect was a result of damage of
corneal sensory nerve. The nerve was af-
fected by herpes, retrobulbar injection,
surgical removal of tumors, meningitis or
multiple ocular surgery.
The amniotic membrane has several
properties that are useful in managing of
epithelial defects: it prevents mechanical
trauma caused by lids because it serves
as biological bandage lens, it prevents ex-
posure and dryness and it promotes ocu-
lar surface healing2,6,7.
The AMT has been used since 1910.g.
when Davis introduced in general sur-
gery for skin transplantation8. In oph-
thalmology AMT was first reported by De
Roth9 in the reconstruction of conjuncti-
val defects in 1940 Kim and Tseng10 re-
ported a new dimension and possible use
of amniotic membrane transplantation.
They used it in ocular surface reconstruc-
tion in rabbits after removal of the epi-
thelium and limbal lamellar keratectomy.
Recently, amniotic membrane has been
used for ocular reconstruction following
chemical or thermal burns, advanced ocu-
lar cicatricial pemphigoid and Steven
-Johnson syndrome, for pterygium exci-
sion, conjunctival surface reconstruction,
sterile corneal ulceration and symptom-
atic bullous keratopathy11.
The amniotic membrane is composed
of monolayer epithelial cells, a basement
membrane, and an avascular stromal ma-
trix12. The membrane permits rapid epi-
thelization due to various mechanisms: it
facilitates migration of epithelial cells,
reinforces adhesion of basal epithelial
cells, promotes epithelial differentiation
and prevents epithelial apoptosis. The
stromal side of the membrane also con-
tains a component that suppresses TGF-
signaling, and the proliferation and dif-
ferentiation of myofibroblast of normal
corneal and limbal fibroblasts and nor-
mal human corneal and limbal fibro-
blasts13. This action explains why ATM
prevents recurrent scarring after ptery-
gium removal11. Furthermore amniotic
membrane produces basic fibroblast
growth factor, hepatocyte growth factor
and transforming growth factor , while
stromal matrix excludes inflammatory
cells and contains several forms of prote-
ase inhibitors14. These properties are the
reason why stromal inflammation is re-
duced after AMT and corneal neovascu-
larization is mitigated.
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Because of all the mentioned reasons
AMT can be considered as an effective ap-
proach for treating persistent sterile cor-
neal ulcerations. In our study we have
applied amniotic membrane in 11 cases
in which the epithelization occurred in
less than 2 weeks postoperatively.
This result is consistent with previous
reports in which ATM was used to treat
corneal ulcers. Lee et al.6 performed AMT
in 11 eyes with corneal ulcerations cau-
sed by different causes and healed 10 of
11 eyes. Kruse at al. (1999)7 reported
about corneal ulcerations treated by mul-
tilayer AMT and 9 of 11 remained stable
for l year. In accordance with this report
we have also noted that the ocular sur-
face inflammation was reduced after
AMT. These findings support recent stud-
ies showing that the stromal matrix of
the amniotic membrane excludes inflam-
matory cells, contains various forms of
protease inhibitors, and suppresses trans-
forming growth factor  (TGF ) signaling
as well as proliferation and myofibroblast
differentiation of normal human corneal
and limbal fibroblasts14. A recent study
also showed that preserved amniotic
membrane expresses mRNAs for several
growth factors and contains different
growth factor proteins that can help the
epithelisation12.
Pain relief after AMT is associated
with restoration of corneal epithelial in-
tegrity and can be contributed to the the-
rapeutic effect of amniotic membrane.
As Tseng recently pointed out, amnio-
tic membrane firstly provides a new base-
ment membrane; secondly exerts an anti-
inflammatory effect; thirdly has a direct
anti-scarring effect; fourthly the combi-
nation of the above three actions may
help re-establish a micro-environmental
niche that is conductive for the growth of
epithelial progenitor cells; and fifthly the
amniotic membrane may promote nerve
regeneration by maintaining nerve growth
factor (NGF) signalling15.
In some cases the use of amniotic
membrane can even eliminate the need
for penetrating keratoplasty12. AMT is
particularly beneficial in countries with
the lack of grafts16,17. The technique is
simple, easy to perform with no addi-
tional serious adverse effects for the pa-
tient.
It is questionable whether the success
of AMT depends upon how long the epi-
thelial defect has persisted before amni-
otic membrane transplantation. In our
small group of patients, most of them
have suffered from neurotrophic ulcers
longer than 11 months before AMT and
all of them have tried prior to AMT all
conventional treatment methods. We
could not be sure whether this method
should be performed immediately when
the first signs of neurotrophic ulcera ap-
pear or delayed until all conventional
treatment failed, as was the case in our
analyzed group. Although our results
clearly indicate a beneficial effect of AMT
for ocular surface reconstruction in ne-
urotrophic corneal ulcera, a larger, ran-
domized, probably multicentric study
should be performed to answer all the
questions which are still open, particu-
larly the issue when would be the optimal
time to perform amniotic membrane
transplantation in these patients.
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TRANSPLANTACIJA AMNIJSKE MEMBRANE U REKONSTRUKCIJI
POVR[INE OKA KOD NEUROTROFNOG ULKUSA RO@NICE
S A @ E T A K
Cilj studije bio je analizirati u~inkovitost transplantacije humane amnijske mem-
brane kod neuroparaliti~kog ulkusa. Kod 11 o~iju aplicirana je amnijska membrana od
sije~nja 1999. godine. Razdoblje pra}enja bilo je du`e od 12 mjeseci: 19,76,0 mjeseci.
Period cijeljenja rane nakon operacije bio je 1,60,6 tjedana. Sve ro`nice bile su fluore-
scein negativne i 12 mjeseci nakon operacije. Kod 8 o~iju vidna o{trina nakon trans-
plantacije bila je identi~na onoj prije operacije. Kod 3 oka vidna o{trina je nakon ope-
racije bila bolja. Transplantacija amnijske membrane mo`e se smatrati efikasnom
alternativom terapije perzistiraju}ih defekata epitela ro`nice, kao {to je to neuropara-
liti~ki ulkus. Ona ima odre|ene prednosti pred transplantacijom ro`nice: jednostavna
operativna tehnika, nema odbacivanja transplantata i dobrodo{la je zamjena u zem-
ljama s nedostatkom transplantata ro`nice.
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